Wide-complex tachycardia: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
==Background==
==Background==
Consider hyperkalemia & dig toxicity
*Consider hyperkalemia & dig toxicity


==Treatment (Wide)==
==Treatment==
#Pulseless --> shock (sync 360J)
#Pulseless - Unsynchronized cardioversion 200J
#Unstable --> shock (sync 100J -200J monophasic, or 50-100J biphasic)
#Unstable - shock (sync 100J -200J monophasic, or 50-100J biphasic)
#Stable
#Stable
##Regular
##Regular (tx as presumed V-tach)
###Tx as presum V.Tach
###1st Line
####1st Line
####Procainamide (20mg/min)
#####Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
####Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
######Agent of choice in setting of AMI or LV dysfunction
#####Agent of choice in setting of AMI or LV dysfunction
#####Procainamide (15-18mg/kg over 30 min)
###2nd Line
####2nd Line
####Lidocaine 1-1.5mg/kg IV q5min, repeat prn until up to 300mg/hr
#####Lidocaine 1-1.5mg/kg IV q5min, repeat prn until up to 300mg/hr
###Torsades de Pointes
####Torsades de Pointes
####Mag 1-2gm IV over 60-90s, then infuse 1-2gm/hr
#####Mag 1-2gm IV over 60-90s, then infuse 1-2gm/hr
###Synchronized cardioversion (100 J)
###May cardiovert
###See Refractory
##Irregular
##Irregular
###HR <200
###Unsynchronized cardioversion (200J)
####Presum aberrant a. fib
 
###HR 200-250
###HR >250
==DDx Regular==
==DDx Regular==
#V. tach
#V-tach
#Tachycardia + BBB
#Tachycardia + BBB
#Tachycardia + rate related BBB
#Tachycardia + rate related BBB
Line 34: Line 29:


==DDX Irregular==
==DDX Irregular==
#A.fib + BBB
#A-fib + BBB
#A.fib + rate related BBB
#A-fib + rate related BBB
##QRS widest with shortest R-R
##QRS widest with shortest R-R
#V. tach
#V-tach
#A.fib + hyperkalemia or meds
#A-fib + hyperkalemia or meds
#Accessory pathway
#Accessory pathway
##The danger = A.fib + aberrant pathway (in WPW)
##The danger = A.fib + aberrant pathway (in WPW)
###do not use adenosine, beta blockers, dilt, or dig
###Do not use adenosine, beta blockers, dilt, or dig
###changing morphology of QRS = inc poss
###Changing morphology of QRS = inc poss
###consider procainamide or ibutilide (amiodarone?)
###Consider procainamide or ibutilide
###shock if becomes unstable
###Shock if becomes unstable
 
==REFRACTORY V-TACH==
#Overdrive pacing
#Lidocaine
#Magnesium
#Electrolytes
#?dilantin


==See also==
==See also==

Revision as of 21:09, 10 May 2011

Background

  • Consider hyperkalemia & dig toxicity

Treatment

  1. Pulseless - Unsynchronized cardioversion 200J
  2. Unstable - shock (sync 100J -200J monophasic, or 50-100J biphasic)
  3. Stable
    1. Regular (tx as presumed V-tach)
      1. 1st Line
        1. Procainamide (20mg/min)
        2. Amiodarone (150mg over 10min, then 1mg/min gtt x 6hrs)
          1. Agent of choice in setting of AMI or LV dysfunction
      2. 2nd Line
        1. Lidocaine 1-1.5mg/kg IV q5min, repeat prn until up to 300mg/hr
      3. Torsades de Pointes
        1. Mag 1-2gm IV over 60-90s, then infuse 1-2gm/hr
      4. Synchronized cardioversion (100 J)
    2. Irregular
      1. Unsynchronized cardioversion (200J)

DDx Regular

  1. V-tach
  2. Tachycardia + BBB
  3. Tachycardia + rate related BBB
  4. Hyperkalemia, meds (e.g. procainamide, flecainide, TCAs, dig)
  5. Pacemaker
  6. Tachycardia + Accessory pathway
  7. See V Tach vs. SVT

DDX Irregular

  1. A-fib + BBB
  2. A-fib + rate related BBB
    1. QRS widest with shortest R-R
  3. V-tach
  4. A-fib + hyperkalemia or meds
  5. Accessory pathway
    1. The danger = A.fib + aberrant pathway (in WPW)
      1. Do not use adenosine, beta blockers, dilt, or dig
      2. Changing morphology of QRS = inc poss
      3. Consider procainamide or ibutilide
      4. Shock if becomes unstable

See also

ACLS (2010 Guidelines)

V Tach vs. SVT

Source

Rosen's